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VaccineThe NP and M2 proteins of inﬂuenza A viruses are cleaved by caspases. M2 cleavage occurs with both
human and avian viruses, whereas NP cleavage is speciﬁc for human strains. In the present study we have
modiﬁed fowl plaque virus (A/FPV/Rostock/34 (H7 N1)) by introducing the NP cleavage site and removing
the M2 cleavage site and have analyzed the effects of these modiﬁcations on virus growth and
pathogenicity. The viruses generated by reversed genetics were: mutant NPgd which had the NP cleavage
site METD↓G17, recombinant wild type virus and mutant NPdel with the non-cleavable motifs METGG17 and
MET-G17, respectively, and mutant M2nn in which the M2 cleavage site VDVD↓DG89 of wild type virus was
replaced by the non-cleavable sequence VNVNDG89. Mutant NPgd replicated in cell cultures and in chicken
embryos equally well as wild type virus and mutant NPdel. This observation was in contrast to previous
results obtained with the human WSN strain that required caspase cleavage of NP for optimal virus growth.
Thus, it appears that acquisition of the NP cleavage site is an adaptive mutation promoting interspecies
transmission from an avian to a mammalian host. Like mutant NPgd, mutant M2nn virus did not show
replication defects in cell culture and in chicken embryos. However, there was a reduction in pathogenicity
for chickens, that was moderate with NPgd and dramatic with M2nn. Single injections with NPgd and
M2nn at low doses induced high antibody titers and protected chickens from lethal FPV infection. These
results show that a highly pathogenic avian inﬂuenza virus can be attenuated by modulating the caspase
cleavage sites of NP and M2 and that these sites should be considered as novel targets for the design of live
vaccines.
© 2009 Elsevier Inc. All rights reserved.Introduction
It has long been known that the NP protein of human inﬂuenza A
viruses undergoes proteolytic cleavage in infected cells (Zhirnov and
Bukrinskaya 1981). Cleavage is exerted by caspases late in the
replication cycle when cells are apoptotic. It occurs at the sequence
METD↓G17 resulting in the removal of a 3-kDa fragment from the
amino-terminal end of NP (Zhirnov et al., 1999, 2003). NP cleavage is
not observedwith avian inﬂuenza viruses (Zhirnov 1984; Zhirnov and
Bukrinskaya 1984), since these viruses have the sequence METGG17 at
this site that is not susceptible to caspases (Zhirnov et al., 1999). The
M2 protein of inﬂuenza A viruses undergoes also caspase processing
involving the loss of a 2-kDa fragment from the C-terminal end by
cleavage at the sequence VDVD↓DG89. M2 cleavage is observed with
both avian and human inﬂuenza A viruses (Zhirnov et al., 2002). It
should be mentioned that this cleavage sequence corresponds to theropean Inﬂuenza Conference,
ll rights reserved.canonical caspase cleavage motif X1DX2DDG common to all inﬂuenza
A viruses M2 (Zhirnov et al., 2002) and is expected to have double
sensitivity to cysteine-type caspases and serine-type granzyme B
(Backes et al., 2005).
In an attempt to throw light on the biological role of NP cleavage
we have recently generated by reverse genetics a mutant of the
human WSN strain in which the NP cleavage site was replaced by
the non-cleavable sequence of the avian viruses. The mutant grew
only to low titers and reverted to the wild type already after 1–2
passages in cell cultures and chicken eggs indicating that NP
cleavage is of replicative advantage for this virus (Zhirnov et al.,
2003).
In the present study we have analyzed the role of caspase
processing in replication of the highly pathogenic avian inﬂuenza
virus A/FPV/Rostock/34 (H7 N1) by generating recombinant viruses
in which the M2 cleavage site was destroyed and the NP cleavage site
was restored. These alterations did not interfere with the replication
potential of the FPV mutants, but reduced their pathogenicity for
chickens. We have identiﬁed therefore modulation of caspase
cleavage of NP and M2 as a new mechanism allowing attenuation of
a highly pathogenic avian inﬂuenza virus.
Fig. 2. Growth curves in MDCK cells. MDCK cells were infected with WTR (♦) and
mutants NPdel (■), NPgd (▲), and M2nn (●) at an MOI 1. Virus titers in culture ﬂuid
were determined at different intervals after infection using a focus assay in MDCK cells.
Ordinate — lg of plaque forming units (p.f.u.) per ml of culture ﬂuid. Abscissa — hours
after infection.
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Generation of caspase cleavage mutants of FPV
Given the high conservation of the caspase motifs at the N-
terminus of NP and at the C-terminus of M2 it was of interest to
elucidate the functional role of proteolytic cleavage at these sites by
mutational analysis. We therefore generated recombinants of FPV
with mutations in the respective genes. We ﬁrst introduced the NP
cleavage site speciﬁc for all human strains into FPV by mutating the
non-cleavable sequence METGG17 to METD↓G17 (mutant NPgd). We
then made a virus lacking the M2 cleavage site by replacing the
caspase motif VDVD↓DG89 with the non-cleavable motif VNVNDG89.
This mutant was designated M2nn. In addition, a NP deletion mutant
with the sequence MET-G17 (mutant NPdel) and recombinant wild
type virus (WTR) were used.
MDCK cells, CACO-2 cells, and chick embryo ﬁbroblasts (CEF) were
then inoculated with these viruses, and analyzed for cleavage of NP
and M2 at late apoptotic stages of infection. The results obtained with
MDCK cells are shown in Fig. 1A. Viruses lacking a caspase motif in NP
(WTR, NPdel, M2nn) displayed only full length (56 kDa) NP, whereas
the cleavage produced aNP (53 kDa) was detected in cells infected
with mutant NPgd containing NP with a caspase motif. In contrast,
both intactM2 (15 kDa) and truncated aM2 (13 kDa)were detected in
cells infected with WTR, NPdel, and NPgd containing unaltered FPV
M2, whereas cleaved M2 was not seen when M2 was mutated as was
the case with the M2nn variant. Similar results were obtained in CEF
and CACO-2 cells (not shown). It should be mentioned that the
mutation in the M2 cytoplasmic tail did not disturb incorporation of
the mutant protein into virions and that the M2/M1 ratio was similar
in virus progeny synthesized in eggs infected with WTR, NPdel, NPgd,
and M2nn (Fig. 1B). Like aNP (Zhirnov and Bukrinskaya, 1981), aM2Fig. 1. Cleavage of NP and M2 in MDCK cells and eggs. MDCK cells (A) and 10-day-old
chicken eggs (B) were infected with WTR, NPdel, NPgd, and M2nn mutants at an MOI 5
of p.f.u. per cell or 100 p.f.u. per egg, respectively. MDCK lysates were subjected 25 h.p.i.
to PAGE and Western blot analysis using antibodies speciﬁc for NP and M2 and HRP
conjugated secondary antibodies (A). Allantoic ﬂuid of infected eggs (35 h.p.i.) was
clariﬁed to remove cell debris, and virions were pelleted through a 2,5-ml layer of 20%
sucrose at 23,000 rpm for 2.5 h (rotor SW 55, Spinko L-7) followed by Western blot
analysis of M2 and M1 (B). Western blots were scanned to determine the amount of
aM2 (percentage of total M2) (A), and the ratio of M1/M2 (B).accumulated in infected cells in amounts similar to the native M2
while only the latter one was incorporated into virions grown in
embryonated eggs (Fig. 1B) and MDCK cells (not shown). Taken
together with our previous studies, these results demonstrate the NP
and M2 undergo proteolytic cleavage in a strain dependent fashion
and that cleavage exerted by ubiquitous host caspases prevents
incorporation of truncated proteins into virions.
Replication, cytotoxicity, and stability of caspase mutants in cell cultures
and chicken eggs
When infected under one-cycle growth conditions, WTR as well as
mutant viruses grew to similar titers in MDCK cells and displayed
comparable kinetics. Only M2nn virus was slightly delayed in the
logarithmic replication phase (Fig. 2). Essentially the same results
were obtained when CEF and CACO-2 cells were used (data not
shown). Likewise, all viruses formed infectious foci in these cells with
similar efﬁciency (Fig. 3). These observations indicate that cultured
cells of different origin allow productive replication of the caspase
mutants.
Since caspases are recruited in apoptosis (Timmer and Salvesen,
2007), one can speculate that alteration of the caspase recognition
sites on NP and M2 might alter the apoptotic properties of the virus.
We have therefore compared the development of apoptosis mutants
in MDCK cells infected with WTR and mutant viruses. When analyzed
16–20 h after infection, levels of apoptotic DNA laddering (Fig. 4A) as
well as apoptotic cleavage of procaspase 3 and poly (ADP-ribose)
polymerase (PARP) to 3a and aPARP, respectively, were found to be
similar in cells infectedwithWTR and caspasemutants (Fig. 4B). Thus,
the caspasemutants induced apoptosis in infected cells as did thewild
type virus.
To compare cell death developing in cell cultures infected with
different caspase mutants, a CytoTox test was applied. This calori-
metric test measured levels of LDH released due to cell death into
culture ﬂuid and thereby reﬂected virus apoptotic cytotoxicity. Data
obtained in a typical experiment are shown in Fig. 4C. It can be seen
that (i) cell damage was maximal in all cultures around 15 h.p.i. and
(ii) cell death developed with similar rates in cultures infected with
both caspase mutants and wild type recombinant virus. Thus, the
proapoptotic cytotoxic abilities of the caspase mutants studied and
WTR virus did not differ signiﬁcantly.
We have then analyzed virus replication in embryonated chicken
eggs (Fig. 5 A, B). WTR and the caspase mutants grew in the allantoic
Fig. 3. Focus formation in cell cultures. Monolayers of canine (MDCK), human (CACO-2), and chicken (CEF) cells were infected with different dilutions of WTR, NPdel, NPgd, and
M2nn. 25 h.p.i. (MDCK) and 40 h.p.i. (CACO-2, CEF) cell monolayers were ﬁxed and stained with anti-FPV antibodies and TMB-insoluble dye. Cell monolayers were examined and
photographed.
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insigniﬁcant difference between WTR and mutant viruses (pN0.05).
Noteworthy, with most viruses, the allantoic ﬂuid was intensively
hemolytic at 40 h.p.i. However, hemolysis was not observed after
infection with mutant M2nn suggesting that this virus was less toxic.
To throw light on the genetic stability of the caspase mutants,
NPgd and M2nn were subjected to three sequential passages at MOI
0,1 in CACO-2, MDCK and CEF cells or in chicken embryos. NP and M2
of progeny virus were then analyzed by sequencing the respective
RNA genes and by polyacrylamide gel electrophoresis for caspase
cleavage in MDCK cells infected with passaged variants. Under these
conditions, the cleavage site mutations were found to be unchanged
indicating that the mutations at the cleavage sites of NP and M2 were
stable and did not revert to the wild type during virus passages.
Pathogenicity of caspase mutants for chickens
Wehave then determined the pathogenicity in 11-day-old chickens.
In theﬁrst series of experiments, groups of four animalswere inoculated
intramuscularly with ten-fold dilutions in the range of 101–105 p.f.u.
per chicken of either WTR, NPdel, NPgd, or M2nn. WTR and Npdel
killed all chickens already at the lower inoculation dose used. With an
LD50 of about 102 p.f.u.. the pathogenicity of NPgd was slightly reduced.
In contrast, when infected with M2nn, all birds survived inoculation
doses of as high as 105 p.f.u., indicating that this mutant had a very low
pathogenicity (Fig. 6A).
To further compare disease development, chickens were infected
with a low dose (ca. 20 p.f.u. per animal) of each virus, and signs of
illness were monitored. WTR and NPdel infected chickens showed a
rapid loss of moving activity, appetite, and body weight, and all of
these animals died within 4–5 days postinfection (Fig. 6B, C). It was
also observed that body temperature in these birds was transiently
elevated by 1–2 °C on days 2–3 and then rapidly dropped before death(Fig. 6D). In contrast, all animals infected with mutants NPgd and
M2nn survived. Some of these animals, in particular after infection
with NPgd, developed transient signs of disease with rufﬂed feathers,
lowered appetite and reduced body weight, yet always recovered
around days 7–8 postinfection (Fig. 6B–D).
To analyze spread of infection in the animals, virus titers were
determined in blood and cloacal swabs at various times after
intramuscular inoculation of low virus doses (Table 1). Animals
infected withWTR and NPdel displayed high virus titers in both blood
and cloaca throughout infection until death. After infection with NPgd
there was transient viremia withmoderate virus titers at days 2 and 5,
but virus was never detected in cloacal swabs. Infection with M2nn
resulted only in minute blood titers with some of the animals on the
second day. Thus, there was efﬁcient replication and dissemination of
WTR andmutant NPdel, whereas this was not the case with NPgd and,
in particular, with M2nn.
Taken together, these results indicate thatWTR and mutant NPdel,
like genuine FPV, are highly pathogenic viruses causing systemic
infection with lethal outcome. Mutant M2nn, on the other hand, is a
highly attenuated virus that does not disseminate and does not cause
disease. Mutant NPgd is in between these extremes.
Immunization of chickens with mutants NPgd and M2nn
Groups of ﬁve 11-day-old chickens were immunized by intramus-
cular inoculation of 5 p.f.u. of either NPgd or M2nn and observed over
a period of 40 days. Three non-immunized animals were used as
control. On day 21 after immunization all animals were challenged
with a high lethal dose of genuine wild type FPV. All chickens
immunized with NPgd and M2nn survived without disease symp-
toms, whereas the non-immunized control animals died within 3–5
days. After challenge, sera were collected from immunized birds and
analyzed for HA-inhibiting antibodies. The data obtained in chickens
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were observed under vaccination with NPgd virus (not shown). It is
seen that on day 10 after immunization antibody titers ranged
between 29 and 211. Three days after challenge they increased toFig. 4. Apoptosis markers in cells infected with virus caspase mutants. MDCK cells were
infected with WTR, NPdel, NPgd, and M2nn mutants at MOI 1. (A) Apoptotic DNA
laddering. At 16 h.p.i. cellular chromatin DNA was analyzed in 1% agarose gel stained
with ethidium bromide. (B) Formation of the apoptotic 24 kDa subunit 3a of procaspase
3 (34 kDa) and of the apoptotic 85 kDa subunit of the PARP precursor (110 kDa). Equal
amounts of cellular polypeptides obtained at 16 h.p.i. were subjected to PAGE-WB
analysis using antibodies speciﬁc for the caspase subunit 3a, and PARP. β-Actin (46
kDa) was assayed with anti-actin antibody in parallel as a quantity reference. WB
membranes were developed by ECL procedure using West Dura supersignal (Pierce).
Western blots were scanned to determine the amount of aPARP (percentage of total
amount of PARP plus aPARP) and caspase 3a (percentage of actin). (C) Dynamics of
apoptotic cell death. LDH released from dying cells was measured in culture ﬂuid at
different intervals after infection by CytoTox-96 test. Ordinate — % of cell death as
compared to 100% control (maximal LDH level due to artiﬁcial cell damage with non-
ionic detergent Triton X-100). Abscissa — hours after infection.
Fig. 5. Virus titres in the allantoic cavity of infected chicken eggs. 10-day-old chicken
embryos were infected with 50 p.f.u. of either WTR, NPdel, NPgd, or M2nn (4 eggs for
each virus). At 20 (A) and 40 (B) h.p.i. allantoic ﬂuids were withdrawn and virus titres
were determined by focus assay in MDCK cells. Logarithmic mean values of p.f.u. per ml
of allantoic ﬂuid supplied with standard deviation bars are shown. Statistical analysis
was performed by Student’s t-test.212–214 and stayed at comparable levels for the remaining observa-
tion period. These results demonstrate that immunization with a
single dose of the attenuated mutants raised high antibody titers that
protected the animals from lethal FPV infection.
Discussion
This study was undertaken to throw light on the biological role of
NP andM2 processing by caspases. The caspase cleavage site of NP is a
speciﬁc feature of human inﬂuenza A viruses. Its absence in avian
strains prompted us to introduce it into NP of FPV. The resulting virus
mutant NPgd showed reduced pathogenicity for chickens, but
replication efﬁciency in cell culture and chicken embryos was not
affected. Since replication rates were markedly reduced when the
caspase cleavage site was removed from NP of the WSN and other
human strains (Zhirnov et al., 2003; Lipatov et al., 2008), it appears
that NP processing is required for optimal growth of human viruses,
whereas this is not the case with avian strains. The acquisition of a
caspase cleavage site by NP may therefore be essential for the
adaptation of an avian virus to man and could be used as a marker for
an emerging pandemic virus.
The WSN study showed also that the mutant lacking the NP
cleavage site rapidly reversed to wild type virus after 1–2 passages in
cell cultures or in chicken eggs indicating that the mutation was
disadvantageous for WSN virus. In contrast, the NP mutation of FPV
described here was stable during virus passages both in human and
avian cells and chicken eggs. This observation implies that avian
viruses are more tolerant to mutations at this site than human viruses
and it supports the concept that inﬂuenza virus when crossing the
Table 1
Virus titers in blood and cloaca of chickens infected with caspase mutants.
Viruses Virus titers(⁎)
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of adaptive mutations without loosing ﬁtness for the old host (Gabriel
et al., 2007).Day 2 Day 5 Day 7
C B C B C B
WTR 3.1×102 2.7×105 2.7×104 1.7×106
0.8×103 1.3×106 3.5×103 4.6×105 –(⁎⁎) –
0.5×103 2.5×106 – –
NPdel 1.1×103 2.7×105 0.5×102 2.7×105
0.7×104 1.3×106 2.5×103 0.7×106 – –
2.5×103 2.1×106 – –
NPgd b101 2.7×102 b101 2.7×101 b101 b101
b101 1.3×104 b101 0.7×102 b101 b101
b101 2.7×102 b101 1.7×102 b101 b101
M2nn b101 3.8×101 b101 b101 b101 b101
b101 1.3×101 b101 b101 b101 b101
b101 b101 b101 b101 b101 b101
(⁎) 11-day-old chickens were infected with 20 p.f.u. of either WTR, NPdel, NPgd, or
M2nn virus. 2, 5 and 7 d.p.i. blood samples (B) and cloaca swabs (C) were prepared
from three animals in each group, and virus titers were measured by focus assay in
MDCK cells. Virus titers were calculated as p.f.u. per ml of blood or cloacal suspension.
(⁎⁎) not survived animals.When the caspase cleavage site of M2 that is common to all
inﬂuenza A viruses was artiﬁcially destroyed, again there was a loss in
pathogenicity of FPV for chickens without a signiﬁcant effect on
replication efﬁciency in cultured cells and chicken embryos. However
as compared to the NP mutation the pathogenicity of mutant M2nn
was reduced dramatically. With an LD50 of about 105 p.f.u. it was
similar to that of an apathogenic avian inﬂuenza virus. Thus, caspase
cleavage of M2 is clearly a pathogenicity determinant of avian
inﬂuenza virus. It will be interesting to ﬁnd out whether this is also
the case with human strains.
The mechanism by whichM2 cleavage affects pathogenicity of FPV
is unclear as is the functional role of the adaptive mutation of human
strains. It has been reported that the cytoplasmic tail of M2 is involved
in virus assembly and that extended tail deletions caused growth
defects in cultured cells (McCown and Pekosz, 2005, 2006; Iwatsuki-
Horimoto et al., 2006). However, such a mechanism is unlikely to
provide an explanation for the drop in pathogenicity observed here,
since there was no effect on replication efﬁciency of FPV. Caspase
cleavage site motifs bind, besides caspases, other host factors, such as
granzymes, that have been reported to be involved in the regulation
of inﬂammation processes (Martinon and Tschopp, 2007). Whether
the caspase motifs of NP and M2 have a scavenger function for these
factors or whether cleavage itself plays a role remains to be seen. In
any case it is tempting to speculate that mechanisms are involved that
interfere with host defense.
The results obtained here on FPV might open a new avenue
towards inﬂuenza live vaccines for the following reasons. First,
mutation of the caspase cleavage site of M2 in particular caused a
massive reduction in pathogenicity. Second, only a single injection of a
few p.f.u. elicited high antibody titers and protected chickens against
challenge with a lethal dose of FPV. Third, mutants with altered
caspase motifs in M2 and NP were relatively stable when passaged in
cultured cells and embryonated eggs. To increase safety andminimize
the risk of reversion to the pathogenic wild type, attenuation could be
further stabilized by, e.g. , combinedmutations of caspasemotifs in NPFig. 6. Course of infection in chickens. 11-day-old chickens were injected intramuscularly
with different virus doses ranging from 5 to 5×104 p.f.u. Animals were examined on
regular intervals for their behavior, bodyweight and survival. (A) Survival rates on day 15
p.i. as depending on the dose of infection. Groups of animals were used for each dose.
Arrow indicates infection time (B, C). Body weight of individual animals and (D) average
body temperature of groups of three animals infected with different viruses. Body weight
and body temperature were determined on animals infected with 30 p.f.u. Viruses are
marked as follows WTR (♦), NPdel (■), NPgd (▲) and M2nn (●).
Fig. 7. Antibody response in chickens vaccinated with M2nn virus. Groups of ﬁve 11-day-
old chickenswere intramuscularly vaccinatedwith 10 p.f.u. ofM2nnvirus (day 0). 21 days
after vaccination, all chickens were infected with a lethal dose (104 p.f.u.) of ﬁeld type
A/FPV/Ro/34 virus (challenge infection). On days 10, 25, and 40 after vaccination,
specimens of blood were taken (bleedings 1, 2, and 3, respectively) and serum anti-
body titers were determined by HAI test. Ordinate shows lg2 of mean value of the HAI
titer suppliedwith standarddeviation bars. Statistical analysiswas performedby Student's
t-test.
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2005; Gabriel et al., 2008) and deletions in the NS1 protein (Ferko et
al., 2004; Richt et al., 2006). Future studies will have to showwhether
this strategy will apply only to highly pathogenic avian inﬂuenza
viruses or to human strains, as well.
Materials and methods
Cells and viruses
Madin Darby canine kidney (MDCK-II) cells (collection of the
Institute of Virology, Marburg), a human epithelial colon carcinoma
cell line (CACO-2) (European Collection of Cell Cultures; ECACC) and
chick embryo ﬁbroblasts (CEF) prepared from 10-day-old embryos
were passaged in Dulbecco's minimal essential medium (DMEM)
containing 10% bovine fetal calf serum (FCS) (Invitrogen; Karlsruhe,
Germany). A/FPV/Rostock/34 (H7 N1) wild type virus was grown in
10-day-old embryonated chicken eggs. For infection, 2-day-old
conﬂuent cell monolayers were incubated with inﬂuenza virus
mutants (5 p.f.u./cell) grown in MDCK cells for 1 h at 37 °C. After
infection, cells were washed and incubated with DMEM without
serum at 37 °C for different periods of time and were then prepared
either for RNA isolation or protein gel electrophoresis.
Generation of recombinant viruses with caspase motif mutations
Virus was recovered from allantoic ﬂuid, and viral RNA was
isolated using the High Pure RNA Isolation Kit (Roche Molecular
Biochemicals, Mannheim, Germany). Viral gene segments were
transcribed into DNA and then ampliﬁed employing the OneStep
RT-PCR kit (Qiagen, Hilden, Germany). The primers used contained
restriction endo-nuclease sites for either BspM1 (PB1, NP), Bsa I (PB2,
PA, HA, NA), or BsmB I (M, NS). All virus-speciﬁc fragments were then
inserted into the plasmid pHH21 by the sticky ends technique
(Wagner et al., 2005). For rescue of recombinant FPV, 1 μg of each of
these plasmids was transfected into 2×106 293 T cells along with
expression plasmids encoding the subunits of the inﬂuenza viruspolymerase pcDNA-PB1 (1 μg), pcDNA-PB2 (1 μg), pcDNA-PA (0,2 μg),
and pcDNA-NP (1 μg). The Lipofectamine 2000 transfection reagent
(Invitrogen; Karlsruhe, Germany) was used according to the manu-
facturer's instruction. Four hours post transfection 2×105 MDCK cells
were added and co-cultivated with the transfected 293 T cells in
DMEM containing 0.2% bovine serum albumin (BSA) and 0.5% FCS.
2–3 days post transfection the supernatant containing 104–106
HAU/ml of virus (passage 0) was removed, aliquots were kept at -
80 °C. Viruses were subsequently passaged in chicken eggs (pe1) or
in MDCK cells (pm1), and these passage variants were used in all
experiments. To obtain caspase mutants site-directed mutagenesis
was done with pHH21-FPV-NP and pHH21-FPV-M plasmids using
the Quick-change mutagenesis kit (Stratagene, Amsterdam, the
Netherlands). The following primers were used: 5′-cagcagaatgctgt-
taacgttaacgatggtcattttg-3′ (M2nn/fo); 5′-caaaatgaccatcgttaacgttaaca-
gcattctgctg-3′ (M2nn/re); 5′-tcttacgaacagatggagaccggtgaacgccagaatg-
3′ (NPdel/fo); 5′-cattctggcgttcaccggtctccatctgttcgtaaga-3′ (NPdel/re);
5′-tcttatgagcagatggagaccgacggagagcgccagaatg-3′ (NPgd/fo); 5′-
cattctggcgctctccgtcggtctccatctgctcataaga-3′ (NPgd/re). The mutant
plasmids were then employed for the generation of recombinant
viruses NPgd (containing the caspase cleavage site METD↓G17 in NP),
NPdel (with G16 deleted in NP), and M2nn (with the sequence
VNVNDG89 replacing the caspase cleavage site).
Experiments in chickens
Eleven-day-old chickens (Lohmann Brown; line PK-13) were
infected (0.15 ml i.m.) with various doses of mutant FPV viruses
grown in MDCK cells. Survival and disease signs, such as loss of
appetite and moving activity, loss of body weight, rufﬂed feathers,
etc., were monitored daily. At different intervals after infection blood
samples were prepared and cloacal swabs were taken with brushes
and suspended in 0.4 ml of water containing antibiotics, and virus
titers weremeasured by virus focus assay inMDCK cells. Titers of anti-
viral antibodies in blood samples were determined by hemagglutina-
tion inhibition (HAI) test with wild type A/FPV/Ro/34 virus grown in
chicken eggs as reference. 30 μl aliquots of two-fold serially diluted
chicken sera were incubated with 30 μl of reference virus (8 HA units)
at 22 °C for 1 h followed by incubation with 60 μl of 1% human red
blood cells (RBC) at 4 °C for 60 min. The HAI titer was deﬁned as the
highest serum dilution that inhibited hemagglutination.
Polyacrylamide gel electrophoresis (PAGE)
Polypeptides were electrophoresed in 12% polyacrylamide gels
using Tris-glycine-SDS buffer followed by autoradiography as pre-
viously described (Zhirnov et al., 1999). For electrophoresis, poly-
peptides were dissociated in 2% SDS, 0.05 M dithiotreitol, 0.02 M Tris–
HCl (pH 6.8) for 10 min at 75 °C.
Western blot analysis (WB)
After SDS-PAGE the polypeptides were transferred from the gel
onto Protran-nitrocellulose membranes (pore size 0.45-μm) (Schlei-
cher and Schuell) by semidry electro-blotting with a Tris–glycine
buffer (pH ∼9.8) containing 15% ethanol. Membranes were incubated
overnight at 4 °C in 3% dried milk in PBS and then incubated for 1 h at
room temperature in PBS containing 1% BSA, with mouse monoclonal
anti-NP (clones A1 and A3; CDC, Atlanta), anti-M2 goat antibody
(donated by A. Hay, London, United Kingdom), anti-PARP mouse
monoclonal (GTX30288, GeneTex, Inc., USA), anti-actin mouse
monoclonal (A5441; Sigma, USA), or anti-caspase 3a rabbit
(ab4051; AbCam, UK) antibodies. After incubation with antibodies,
membranes were exposed to horseradish peroxidase (HRP)-conju-
gated secondary anti-species antibodies (Dako; Hamburg, Germany),
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ﬁlm.Analysis of cell death dynamics
To evaluate levels of cell death in cultures of infected cells, the
CytoTox-96 test (Promega, USA) measuring lactate dehydrohenase
(LDH) activity released from dying cells was applied. MDCK cells
grown on 3-cm dishes and infected with caspase mutants at MOI 1
were covered with 2.3 ml of DMEM and incubated at 37 °C. At
different intervals 50 μl aliquots of culture ﬂuids were clariﬁed at
12,000 g for 5 min, and supernatants were kept at -80 °C. LDH activity
of culture ﬂuid samples was assayed by the tetrazolium-diaphorase
method according to the manufacturer's protocol. Activity was
quantitated measuring wavelength absorbance of the produced red
formazan at 490 nm in a BioRad Microplate Reader 550. Culture ﬂuid
of mock-infected cells and samples of cells lysed with 0.8% Triton X-
100 were monitored as background and 100% maximal reference
controls, respectively.DNA fragmentation analysis
For the isolation of cellular low molecular weight DNA, the SDS-
high salt extraction method has been used (Zhirnov et al., 1999).
Mock-infected and inﬂuenza-infected cells were suspended in 80 μl
PBS and gentlymixedwith 300 μl of buffer containing 10mMTris–HCl
(pH 7.6), 10 mM EDTA, and 0.6% SDS. Cell lysates were incubated
overnight at 4 °C in 100 μl of 5 M NaCl, and centrifuged at 14,000 rpm
for 20 min at 4 °C. Supernatants were treated sequentially with
RNAase A (1 mg/ml) and proteinase K (0.2 mg/ml) for 20 min at
37 °C, mixedwith two volumes of ethanol, and left overnight at -20 °C.
Precipitated DNA was resuspended in TE buffer (10 mM Tris–HCl,
1 mM EDTA, pH 7.6), electrophoresed in 1.5% agarose–TBE buffer, and
stained with ethidium bromide.Focus assay in cultured cells
MDCK, CACO-2 or CEF cells grown in 24-well plates were
incubated with 0.4 ml/well of ten-fold virus dilutions in DMEM.
After 60-min incubation at 37 °C, the virus inoculum was removed,
and cells were washed and covered with 1.0 ml of agarose (culture
quality Sigma, Taufberg, Germany) per well at a ﬁnal concentration of
1% in DMEM containing 0.1% of BSA. 24–48 h after infection, cells were
ﬁxed with 4% paraformaldehyde, and agarose layers were removed.
Fixed cells were incubated for 1 h with anti-inﬂuenza virus antibodies
and after that with horseradish HRP-conjugated secondary anti-
species antibodies (Dako; Hamburg, Germany), followed by visualiza-
tion of virus foci with TMB insoluble substrate “True Blue” (KPL).
Stained virus foci were counted.Acknowledgments
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